COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

29,911 Articles (22,044 medRxiv, 7,867 bioRxiv)

Most recent first Previous |  Page 2964: Articles 29631-29640  | Next

An Effective CTL Peptide Vaccine for Ebola Zaire Based on Survivors' CD8+ Targeting of a Particular Nucleocapsid Protein Epitope with Potential Implications for COVID-19 Vaccine Design
Herst, C. V., Burkholz, S., Sidney, J., Sette, A., Harris, P. E., Massey, S., Brazel, T., Cunha-Neto, E., Rosa, D. S., Chao, W. C. H., Carback, R. T., Hodge, T., Wang, L., Ciotlos, S., Lloyd, P., Rubsamen, R. M.
10.1101/2020.02.25.963546 — Posted: 2020-02-27 Discussion: Onsite
A simple magnetic nanoparticles-based viral RNA extraction method for efficient detection of SARS-CoV-2
Zhao, Z., Cui, H., Song, W., Ru, X., Zhou, W., Yu, X.
10.1101/2020.02.22.961268 — Posted: 2020-02-27
Spike protein binding prediction with neutralizing antibodies of SARS-CoV-2
Park, T., Lee, S.-Y., Kim, S., Kim, M. J., Kim, H. G., Jun, S., Kim, S. I., Kim, B. T., Park, E. C., Park, D.
10.1101/2020.02.22.951178 — Posted: 2020-02-27
Epidemiological Development of Novel Coronavirus Pneumonia in China and Its Forecast
Wu, S. s., Sun, P. p., Li, R. l., Zhao, L., Wang, Y. l., Jiang, L. f., Deng, J. B.
10.1101/2020.02.21.20026229 — Posted: 2020-02-26
Case fatality rate of novel coronavirus disease 2019 in China
Qi, R., Ye, C., Qin, X.-r., Yu, X.-J.
10.1101/2020.02.26.20028076 — Posted: 2020-02-26 Discussion: Onsite
The landscape of lung bronchoalveolar immune cells in COVID-19 revealed by single-cell RNA sequencing
Liao, M., Liu, Y., Yuan, J., Wen, Y., Xu, G., Zhao, J., Chen, L., Li, J., Wang, X., Wang, F., Liu, L., Zhang, S., Zhang, Z.
10.1101/2020.02.23.20026690 — Posted: 2020-02-26 Discussion: Onsite
Deep learning-based model for detecting 2019 novel coronavirus pneumonia on high-resolution computed tomography: a prospective study in 27 patients
Chen, J., Wu, L., Zhang, J., Zhang, L., Gong, D., Zhao, Y., Hu, S., Wang, Y., Hu, X., Zheng, B., Zhang, K., Wu, H., Dong, Z., Xu, Y., Zhu, Y., Chen, X., Yu, L., Yu, H.
10.1101/2020.02.25.20021568 — Posted: 2020-02-26
Genomic variations of COVID-19 suggest multiple outbreak sources of transmission
Zhang, L., Yang, J.-R., Zhang, Z., Lin, Z.
10.1101/2020.02.25.20027953 — Posted: 2020-02-26 Discussion: Onsite
WeChat, a Chinese social media, may early detect the SARS-CoV-2 outbreak in 2019
Wang, W., Wang, Y., Zhang, X., Li, Y., Jia, X., Dang, S.
10.1101/2020.02.24.20026682 — Posted: 2020-02-26
TWIRLS, an automated topic-wise inference method based on massive literature, suggests a possible mechanism via ACE2 for the pathological changes in the human host after coronavirus infection
Ji, X., Zhang, C., Zhai, Y., Zhang, Z., Xue, Y., Zhang, C., Tan, G., Niu, G.
10.1101/2020.02.24.20025437 — Posted: 2020-02-26 Discussion: Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).